Free Trial

Summit Therapeutics (SMMT) Earnings Date, Estimates & Call Transcripts

Summit Therapeutics logo
$20.39
+0.43 (+2.15%)
(As of 11/5/2024 ET)

Summit Therapeutics Latest Earnings Summary

Upcoming Q3
Earnings Date
Feb. 18Estimated
Actual EPS
(Aug. 6)
-$0.05 Beat By $0.01
Consensus EPS
(Aug. 6)
-$0.06

Summit Therapeutics issued Q2 2024 earnings on August 6, 2024, reporting an EPS of -$0.05, which topped the consensus estimate of -$0.06 by $0.01. With a trailing EPS of -$0.28, Summit Therapeutics' earnings are expected to decrease next year, from ($0.27) to ($0.29) per share.

SMMT Upcoming Earnings

Summit Therapeutics' next earnings date is estimated for Tuesday, February 18, 2025, based off prior year's reporting schedules.

Get Summit Therapeutics Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Summit Therapeutics and other key companies, straight to your inbox.

Sign Up
Skip Charts & View Estimated and Actual Earnings Data

SMMT Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

SMMT Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Summit Therapeutics Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q3 20241-$0.06-$0.06-$0.06
Q4 20241-$0.06-$0.06-$0.06
20242-$0.12-$0.12-$0.12
Q1 20251-$0.06-$0.06-$0.06
Q2 20251-$0.06-$0.06-$0.06
Q3 20251-$0.07-$0.07-$0.07
Q4 20251-$0.07-$0.07-$0.07
FY 20254($0.26)($0.26)($0.26)

Summit Therapeutics Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueLinks
2/18/2025
(Estimated)
------- 
8/6/2024Q2 2024-$0.06-$0.05+$0.01-$0.01--
5/1/2024Q1 2024-$0.06-$0.05+$0.01-$0.04--  
2/20/2024Q4 2023--$0.05 -$0.05-$0.05-$0.20M    
11/7/2023Q3 2023--$0.03 -$0.03-$0.03-$0.27M  
8/9/2023Q2 2023--$0.02 -$0.02-$0.02--  
5/11/2023Q1 2023--$0.06 -$0.06$1.31--    
3/9/2023Q4 2022--$0.07 -$0.07-$0.07-$1.13M  
11/9/2022Q3 2022--$0.14 -$0.14-$0.14-$5.68M

Summit Therapeutics Earnings - Frequently Asked Questions

Summit Therapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, February 18th, 2025 based off last year's report dates. Learn more on SMMT's earnings history.

In the previous quarter, Summit Therapeutics (NASDAQ:SMMT) reported ($0.05) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.06) by $0.01. Learn more on analysts' earnings estimate vs. SMMT's actual earnings.

Summit Therapeutics (NASDAQ:SMMT) has a recorded annual revenue of $700,000.00.

Summit Therapeutics (NASDAQ:SMMT) has a recorded net income of -$614.93 million. SMMT has generated -$0.28 earnings per share over the last four quarters.

Summit Therapeutics's earnings are expected to decrease from ($0.27) per share to ($0.29) per share in the next year.

`

More Earnings Resources from MarketBeat



This page (NASDAQ:SMMT) was last updated on 11/5/2024 by MarketBeat.com Staff
From Our Partners